Geode Capital Management LLC has recently announced that it has increased stake in Neximmune Inc (NASDAQ:NEXI) by 75.21%. After grabbing 4326.0 shares, the institutional investor is now in possession of 1857.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 0.41% having worth around $10728.0.
Neximmune Inc (NEXI) concluded trading on 01/03/24 at a closing price of $6.20, with 60.98 million shares of worth about $378.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.42% during that period and on Wednesday the price saw a gain of about 161.05%. Currently the company’s common shares owned by public are about 1.04M shares, out of which, 0.66M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Bridgeway Ultra Small Company Mar are the top 3 mutual funds which are holding stakes in Neximmune Inc Vanguard Extended Market Index Fu is currently holding 3892.0 shares of worth totaling $9652.0. The company recently came selling 1.0 shares which brought its stake up to 0.37% of the company’s outstanding shares. Bridgeway Ultra Small Company Mar, after buying 2000.0 shares, have now control over 0.19% of the stake in the company. It holds 0.0 shares of worth $4960.0.
Neximmune Inc (NASDAQ: NEXI) started trading at $7.35, above $4.97 from concluding price of the previous day. Stock saw a price change of 184.40% in past 5 days and over the past one month there was a price change of 2.48%. Year-to-date (YTD), NEXI shares are showing a performance of 179.28% which increased to 2.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.25 but also hit the highest price of $20.35 during that period. The average intraday trading volume for Neximmune Inc shares is 308.72K. The stock is currently trading 116.67% above its 20-day simple moving average (SMA20), while that difference is up 108.93% for SMA50 and it goes to -0.78% lower than SMA200.
Geode Capital Management LLC acquired 4326.0 shares of Neximmune Inc having value of about $10728.0. Data submitted at the U.S SEC by Geode Capital Management LLC revealed that the firm now holds 1857.0 shares in the company valued at close to $11513.4, or have control over 75.21% stake in the company. Neximmune Inc (NASDAQ: NEXI) currently have 1.04M outstanding shares and institutions hold larger chunk of about 16.11% of that. Holding of mutual funds in the company is about 0.96% while other institutional holders and individual stake holders have control over 15.16% and — of the stake respectively.
The stock has a current market capitalization of $6.57M and its 3Y-monthly beta is at 1.72. It has posted earnings per share of -$267.72 in the same period. It has Quick Ratio of 1.66 while making debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NEXI, volatility over the week remained 23.92% while standing at 17.79% over the month.
Analysts are in expectations that Neximmune Inc (NEXI) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is -$3.75 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$15 in the same quarter a year ago.
Analysts at 1 brokerage firms have issued recommendations for the Neximmune Inc (NEXI)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on April 01, 2021 offering an Outperform rating for the stock and assigned a target price of $30 to it.
